Form 4: Axogen Director Receives Equity Grant

Axogen, Inc. reports an annual equity grant to Director Alan M. Levine, valued at $185,000, vesting in one year.

Summary

• Alan M. Levine, a Director at Axogen, Inc., received an annual equity grant on June 24, 2026.
• The grant consists of Restricted Stock Units (RSUs) representing 4,392 shares of common stock.
• The total valuation of the equity grant was $185,000 as of the grant date.
• These RSUs are scheduled to vest on June 24, 2027, one year after the grant date.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports routine compensation for a director rather than significant operational or financial news.

Positives

• Director Alan M. Levine received an equity grant, indicating continued investment in and commitment to the company's leadership.
• The grant is an annual award for service as a Director, a standard practice for board compensation.
• The equity grant is valued at $185,000, reflecting a significant incentive for the director.

Future Outlook

The Restricted Stock Units granted to Director Alan M. Levine will vest on June 24, 2027, one year after the grant date, subject to continued service.

Industry Context

StockSavvy.ai notes that equity grants to directors are a common practice in the biotechnology and medical device sectors, such as Axogen, Inc., to align executive and board interests with shareholder value and attract/retain talent.

Stakeholder Impact

• Shareholders: The equity grant represents a form of compensation, which impacts dilution and executive compensation costs. However, it also aligns director interests with long-term company performance.
• Employees: This filing does not directly impact employees, but it is part of the overall compensation structure of the company.

Next Steps

• Director Alan M. Levine will hold the Restricted Stock Units until their vesting date on June 24, 2027.
• Upon vesting, the RSUs will convert into 4,392 shares of Axogen, Inc. common stock.

Key Dates

Keywords

Axogen Inc, AXGN, Form 4, SEC Filing, Equity Grant, Restricted Stock Units, Director Compensation, Alan M. Levine